Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 81

1.

Interventions to slow cardiovascular aging: Dietary restriction, drugs and novel molecules.

Heiss C, Spyridopoulos I, Haendeler J.

Exp Gerontol. 2017 Jun 27. pii: S0531-5565(17)30293-0. doi: 10.1016/j.exger.2017.06.015. [Epub ahead of print] Review.

PMID:
28658611
2.

Non-coding RNA regulation of T cell biology: Implications for age-associated cardiovascular diseases.

Coelho-Lima J, Spyridopoulos I.

Exp Gerontol. 2017 Jun 23. pii: S0531-5565(17)30306-6. doi: 10.1016/j.exger.2017.06.014. [Epub ahead of print] Review.

PMID:
28652179
3.

Lymphocyte Communication in Myocardial Ischemia/Reperfusion Injury.

Boag SE, Andreano E, Spyridopoulos I.

Antioxid Redox Signal. 2017 Apr 20;26(12):660-675. doi: 10.1089/ars.2016.6940. Epub 2017 Feb 23. Review.

PMID:
28006953
4.

Microvessels of the heart: Formation, regeneration, and dysfunction.

Spyridopoulos I, Arthur HM.

Microcirculation. 2017 Jan;24(1). doi: 10.1111/micc.12338.

PMID:
27926994
5.

CMV seropositivity and T-cell senescence predict increased cardiovascular mortality in octogenarians: results from the Newcastle 85+ study.

Spyridopoulos I, Martin-Ruiz C, Hilkens C, Yadegarfar ME, Isaacs J, Jagger C, Kirkwood T, von Zglinicki T.

Aging Cell. 2016 Apr;15(2):389-92. doi: 10.1111/acel.12430. Epub 2015 Dec 22.

6.

β-Blockers and ivabradine differentially affect cardiopulmonary function and left ventricular filling index.

Fischer-Rasokat U, Honold J, Lochmann D, Wolter S, Liebetrau C, Fichtlscherer S, Möllmann H, Spyridopoulos I, Hamm CW.

Clin Res Cardiol. 2016 Jun;105(6):527-34. doi: 10.1007/s00392-015-0950-0. Epub 2015 Dec 19.

PMID:
26687495
7.

Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease: the prospective longitudinal trial of FFR(CT): outcome and resource impacts study.

Douglas PS, Pontone G, Hlatky MA, Patel MR, Norgaard BL, Byrne RA, Curzen N, Purcell I, Gutberlet M, Rioufol G, Hink U, Schuchlenz HW, Feuchtner G, Gilard M, Andreini D, Jensen JM, Hadamitzky M, Chiswell K, Cyr D, Wilk A, Wang F, Rogers C, De Bruyne B; PLATFORM Investigators.

Eur Heart J. 2015 Dec 14;36(47):3359-67. doi: 10.1093/eurheartj/ehv444. Epub 2015 Sep 1.

8.

T lymphocytes and fractalkine contribute to myocardial ischemia/reperfusion injury in patients.

Boag SE, Das R, Shmeleva EV, Bagnall A, Egred M, Howard N, Bennaceur K, Zaman A, Keavney B, Spyridopoulos I.

J Clin Invest. 2015 Aug 3;125(8):3063-76. doi: 10.1172/JCI80055. Epub 2015 Jul 13.

9.

Differences in immune responses between CMV-seronegative and -seropositive patients with myocardial ischemia and reperfusion.

Shmeleva EV, Boag SE, Murali S, Bennaceur K, Das R, Egred M, Purcell I, Edwards R, Todryk S, Spyridopoulos I.

Immun Inflamm Dis. 2015 Jun;3(2):56-70. doi: 10.1002/iid3.49. Epub 2015 Mar 1.

10.

Shock-index as a novel predictor of long-term outcome following primary percutaneous coronary intervention.

Spyridopoulos I, Noman A, Ahmed JM, Das R, Edwards R, Purcell I, Bagnall A, Zaman A, Egred M.

Eur Heart J Acute Cardiovasc Care. 2015 Jun;4(3):270-7. doi: 10.1177/2048872614561480. Epub 2014 Nov 25.

PMID:
25425723
11.

Myocardial ischemia and reperfusion leads to transient CD8 immune deficiency and accelerated immunosenescence in CMV-seropositive patients.

Hoffmann J, Shmeleva EV, Boag SE, Fiser K, Bagnall A, Murali S, Dimmick I, Pircher H, Martin-Ruiz C, Egred M, Keavney B, von Zglinicki T, Das R, Todryk S, Spyridopoulos I.

Circ Res. 2015 Jan 2;116(1):87-98. doi: 10.1161/CIRCRESAHA.116.304393. Epub 2014 Nov 10.

12.

Senescent cytotoxic T cells in acute myocardial infarction: innocent bystanders or the horsemen of apocalypse?

Hoffmann J, Spyridopoulos I.

Cell Mol Immunol. 2015 Jul;12(4):510-2. doi: 10.1038/cmi.2014.93. Epub 2014 Sep 22. No abstract available.

13.

Atorvastatin induces T cell proliferation by a telomerase reverse transcriptase (TERT) mediated mechanism.

Bennaceur K, Atwill M, Al Zhrany N, Hoffmann J, Keavney B, Breault D, Richardson G, von Zglinicki T, Saretzki G, Spyridopoulos I.

Atherosclerosis. 2014 Oct;236(2):312-20. doi: 10.1016/j.atherosclerosis.2014.07.020. Epub 2014 Aug 4.

PMID:
25127175
14.

Dietary restriction ameliorates haematopoietic ageing independent of telomerase, whilst lack of telomerase and short telomeres exacerbates the ageing phenotype.

Al-Ajmi N, Saretzki G, Miles C, Spyridopoulos I.

Exp Gerontol. 2014 Oct;58:113-9. doi: 10.1016/j.exger.2014.07.010. Epub 2014 Jul 17.

PMID:
25038516
15.

Telomere length predicts cardiovascular disease.

Spyridopoulos I, von Zglinicki T.

BMJ. 2014 Jul 8;349:g4373. doi: 10.1136/bmj.g4373. No abstract available.

PMID:
25005709
16.

The evidence base for revascularisation of chronic total occlusions.

Bagnall A, Spyridopoulos I.

Curr Cardiol Rev. 2014 May;10(2):88-98. Review.

17.

Ivabradine therapy to unmask heart rate-independent effects of β-blockers on pulse wave reflections.

Fischer-Rasokat U, Honold J, Lochmann D, Liebetrau C, Leick J, Hamm C, Fichtlscherer S, Möllmann H, Spyridopoulos I.

Clin Res Cardiol. 2014 Jun;103(6):487-94. doi: 10.1007/s00392-014-0679-1. Epub 2014 Feb 18.

PMID:
24535377
18.

Randomized trial of preventive angioplasty in myocardial infarction.

Wald DS, Morris JK, Wald NJ, Chase AJ, Edwards RJ, Hughes LO, Berry C, Oldroyd KG; PRAMI Investigators.

N Engl J Med. 2013 Sep 19;369(12):1115-23. doi: 10.1056/NEJMoa1305520. Epub 2013 Sep 1.

19.

Provision of gastroprotective medication and bleeding risk following acute coronary syndrome.

Badar A, Scaife J, Yan AT, Robinson SD, Zaman AG, Purcell IF, Ahmed JM, Egred M, Edwards RJ, Spyridopoulos I, Keavney BD, Bagnall AJ.

J Invasive Cardiol. 2013 Aug;25(8):397-401.

20.

Risk stratification following complex PCI: clinical versus anatomical risk stratification including "post PCI residual SYNTAX-score" as quantification of incomplete revascularization.

Schwietz T, Spyridopoulos I, Pfeiffer S, Laskowski R, Palm S, DE Rosa S, Jens K, Zeiher AM, Schächinger V, Fichtlscherer S, Lehmann R.

J Interv Cardiol. 2013 Feb;26(1):29-37. doi: 10.1111/j.1540-8183.2013.12014.x.

PMID:
23419105

Supplemental Content

Loading ...
Support Center